ArticleBMC genomics2025
BvHP4b gene in red beet promotes tuber enlargement and enhances resistance to Pst DC3000.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Thyme Oil Alleviates Cadmium-Induced Disturbances in Mitotic Activity, Cytoskeletal Organization and H3T3/H3S10 Phosphorylation inInternational journal of molecular sciences · 2026Article
- Advances in Beet (Plants (Basel, Switzerland) · 2025Review
- Genome editing approaches to harness cytokinin-salicylic acid crosstalk for plant protection.Frontiers in genome editing · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One important component of the cytokinin signaling pathway is the histidine phosphotransferase (HP), which plays an essential role in regulating downstream gene expression by transferring phosphate groups. The role of histidine phosphotransfer proteins (HPs) in sugar beets under abiotic and biotic stresses remains unclear. The results showed that the expression of BvHP4b in red beets increased in response to the exogenous hormone 6-BA. Transgenic Arabidopsis seedlings with heterologous expression of BvHP4 T3 lines (BvHP4-OE) displayed enhanced growth and resistance to Pst DC3000. Moreover, the expression of NPR1 and PRs was increased in the T3 transgenic lines compared to the control. Subcellular localization analysis revealed that BvHP4b primarily localized to the cell membrane. Transgenic red beets overexpressing BvHP4b (BvHP4b-OX lines) and bvhp4b mutant plants (KO lines) using CRISPR/Cas9 technology were generated respectively. The BvHP4b-OX lines showed enhanced taproot development, which was attributed to the altered expression of BvXTH33, BvCESA6, BvCDC2, and BvCEL1 genes. These lines also exhibited increased tolerance to Pst DC3000 by regulating synthesis of SA and modulating the expression of genes involved in plant immunity. In contrast, the KO plants were more susceptible to Pst DC3000 compared to the control plants. Furthermore, BvHP4b was shown to interact with BvCDC2 both in vivo and in vitro. Overall, this study suggests that the BvHP4b protein acts as a positive regulator, enhancing taproot enlargement and tolerance to Pst DC3000 in sugar beet plants.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.